GGrantIndex
← Leaderboards

Rany Condos

New York University School Of Medicine

$1,360,254
Attributed
$2,623,265
Total exposure
11
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $853.8K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$2,623,265 · 11

By mechanism

R01$2,526,022 · 1
M01$97,243 · 10

Top collaborators

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Tuberculosis

Research focus

TuberculosisHuman SubjectClinical ResearchInterferon GammaDiagnostic Respiratory LavageCytokineQuestionnairesMycobacterium TuberculosisInterleukin 5Interleukin 2ImmunocytochemistryInterleukin 4Research PersonnelResourcesPatient Oriented ResearchSourceInstitutionIdiopathic Pulmonary FibrosisHuman Therapy EvaluationImmune ResponseFundingGrantBactericidal ImmunityComputer Retrieval Of Information On Scientific Projects Database

Grant awards (21)

Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2$841,864
R01 · FY2025 · HL
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2$830,331
R01 · FY2024 · HL
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2$853,827
R01 · FY2023 · HL
CLINICAL TRIAL: AEROSOL INTERFERON-GAMMA TREATMENT IN IDIOPATHIC PULMONARY FIBRO$4,468
M01 · FY2008 · RR · contact PI
TUBERCULOSIS RESEARCH BLOOD BANK$258
M01 · FY2008 · RR · contact PI
TUBERCULOSIS RESEARCH BLOOD BANK$2,269
M01 · FY2007 · RR · contact PI
AEROSOL INTERFERON-GAMMA TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)$394
M01 · FY2007 · RR · contact PI
AEROSOL INTERFERON-GAMMA TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)$934
M01 · FY2006 · RR · contact PI
MOXIFLOXACIN DURING THE FIRST 2 MONTHS OF TREATMENT FOR PULMONARY TUBERCULOSIS$21,962
M01 · FY2005 · RR
AEROSOL INTERFERON-GAMMA TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)$955
M01 · FY2005 · RR
LUNG CYTOKINE LEVELS IN TUBERCULOSIS INFECTION$477
M01 · FY2005 · RR
Aerosol Interferon-gamma Treatment in Idiopathic Pulmonary Fibrosis (IPF)$18,038
M01 · FY2004 · RR
MOXIFLOXACIN DURING THE FIRST 2 MONTHS OF TREATMENT FOR PULMONARY TUBERCULOSIS$15,240
M01 · FY2004 · RR
Lung Cytokine Levels in Tuberculosis Infection$8,968
M01 · FY2004 · RR
Volatile Markers of Pulmonary Tuberculosis in the Breath$2,274
M01 · FY2004 · RR
LUNG CYTOKINE LEVELS IN TUBERCULOSIS INFECTION$0
M01 · FY2002 · RR
LUNG CYTOKINE LEVELS IN TUBERCULOSIS INFECTION$0
M01 · FY2001 · RR
LUNG CYTOKINE LEVELS IN TUBERCULOSIS INFECTION$21,006
M01 · FY2000 · RR
LUNG CYTOKINE LEVELS IN TUBERCULOSIS INFECTION$0
M01 · FY2000 · RR
AEROSOL INTERFERON GAMMA TREATMENT IN TUBERCULOSIS/AIDS$0
M01 · FY2000 · RR
AEROSOL INTERFERON GAMMA TREATMENT IN TUBERCULOSIS/AIDS$0
M01 · FY2000 · RR